Brief: Pila Pharma Q3 EBIT Loss Narrows To SEK 2.3 Mln
26/10/2022 09:31
Oct 26 (Reuters) - Pila Pharma AB PILA.ST :
* PILA PHARMA PUBLISHES INTERIM REPORT JULY 1 - SEPTEMBER
30, 2022
* Q3 REVENUE WAS SEK 281 KSEK (0)
* Q3 OPERATING LOSS (EBIT) WAS - 2 286 KSEK (- 3 174)
Source text for Eikon: ID:nBQN1ngt9x
Further company coverage: PILA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))